Autor: |
Jose L. Navia, MD, Samir Kapadia, MD, Haytham Elgharably, MD, Gabriel Maluenda, MD, Krzysztof Bartuś, MD, Cristian Baeza, MD, Rajesh K. Nair, MD, Josep Rodés-Cabau, MD, Cesare Beghi, MD, Rodolfo C. Quijano, MD, PhD |
Jazyk: |
angličtina |
Rok vydání: |
2018 |
Předmět: |
|
Zdroj: |
JACC: Basic to Translational Science, Vol 3, Iss 1, Pp 67-79 (2018) |
Druh dokumentu: |
article |
ISSN: |
2452-302X |
DOI: |
10.1016/j.jacbts.2017.08.003 |
Popis: |
Patients with isolated functional or recurrent tricuspid regurgitation are often denied surgery because they are considered to be at high risk. Transcatheter valve therapy provides a less invasive alternative for tricuspid regurgitation associated with right heart failure. We have evaluated the feasibility of transcatheter tricuspid valve implantation of the NaviGate valved stent in a long-term swine model. The valved stent was successfully implanted through transjugular and transatrial approaches on the beating heart with excellent hemodynamic and valve performance. No conduction disturbance or coronary obstruction was observed. This technology could provide an alternative treatment for patients who are at high surgical risk with severe tricuspid regurgitation and compromised right ventricular function. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|